- Ongoing, recruitingTherapeutic confirmatory (Phase III)
Double-blind, Randomized, Placebo-controlled Phase 3 study Evaluating Efficacy and Safety of IgPro20 (subcutaneous immunoglobulin, HIZENTRA®) in post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
This study looks at a medicine called IgPro20 (Hizentra®) for people who have POTS after COVID-19. It aims to see if the medicine can reduce symptoms and make people feel better, compared to a dummy treatment.
For: Post-COVID-19 Postural Orthostatic Tachycardia SyndromeGermany · Italy · Spain - AuthorisedTherapeutic exploratory (Phase II)
A randomized, double-blind crossover study to investigate the analgesic efficacy of the bradykinin (B2) antagonist icatibant for propofol injection pain in healthy adult participants.
This study is looking for healthy adults to test a new medicine idea, icatibant, to see if it can reduce the stinging pain sometimes felt when having an injection of propofol, a medicine used for sleep during medical procedures.
For: PainNorway - AuthorisedHuman Pharmacology (Phase I)- Other
Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients with multi-quadrant peritonitis undergoing abdominal surgery: A randomized placebo-controlled trial (TRIPLE)
This study is testing new treatments for a serious tummy infection called peritonitis. It aims to see if a mix of medicines given during surgery can help patients recover better and reduce problems like further infections or needing more surgery. Researchers want to find the best way to help people get well.
For: peritonitisDenmark